Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: Etanercept or adalimumab?

Rheumatology (United Kingdom)

Volumn 52, Issue 9, 2013, Pages 1674-1679

  Anink, Janneke ^a   Otten, Marieke H ^a   Gorter, Simone L ^b   Prince, Femke H M ^a   van Rossum, Marion A J ^c   van den Berg, J Merlijn ^c   Van pelt, Philomine A ^a   Kamphuis, Sylvia ^a   Brinkman, Danielle M C ^d   Swen, Wijnand A A ^e   Swart, Joost F ^f   Wulffraat, Nico M ^f   Dolman, Koert M ^g   Koopman Keemink, Yvonne ^h   Hoppenreijs, Esther P A H ⁱ   Armbrust, Wineke ^j   Ten Cate, Rebecca ^k   van Suijlekom Smit, Lisette W A ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d RIJNLAND HOSPITAL   (Netherlands)

^e Location Alkmaar   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^h JULIANA CHILDREN S HOSPITAL   (Netherlands)

ⁱ SINT MAARTENSKLINIEK   (Netherlands)

^j UNIVERSITY OF GRONINGEN   (Netherlands)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Decision making; Juvenile idiopathic arthritis; Qualitative research; TNF inhibitors

Indexed keywords

ADALIMUMAB; ETANERCEPT; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; CHILD; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTROLLED STUDY; DISABILITY; DISEASE DURATION; DRUG EFFICACY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERVIEW; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL HISTORY; PEDIATRICIAN; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOLOGY; SCHOOL CHILD; UVEITIS;

DECISION MAKING; JUVENILE IDIOPATHIC ARTHRITIS; QUALITATIVE RESEARCH; TNF-Α INHIBITORS;

ADOLESCENT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DECISION MAKING; DRUG PRESCRIPTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PHYSICIAN'S PRACTICE PATTERNS; RECEPTORS, TUMOR NECROSIS FACTOR; REGISTRIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84882999731     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket170     Document Type: Article

References (26)

1. Lovell DJ, Giannini EH, Reiff A et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000342:763-9.
2. Horneff G, De Bock F, Foeldvari I et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 200968:519-25.
3. Prince FH, Twilt M, ten Cate R et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 200968:635-41.
4. Lovell DJ, Ruperto N, Goodman S et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008359:810-20.
5. Biester S, Deuter C, Michels H et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 200791: 319-24.
6. Simonini G, Cantarini L, Bresci C et al. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev 20109:674-83.
7. Simonini G, Taddio A, Cattalini M et al. Prevention of flare recurrences in childhood refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res 2010, Nov 15.
8. Smith JA, Thompson DJ, Whitcup SM et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 200553:18-23.
9. Tynjala P, Lindahl P, Honkanen V et al. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 200766:548-50.
10. Katsicas MM, Russo RA. Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab. Clin Rheumatol 200928:985-8.
11. Trachana M, Pratsidou-Gertsi P, Pardalos G et al. Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis. Scand J Rheumatol 201140: 101-7.
12. Beukelman T, Patkar NM, Saag KG et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 201163: 465-82.
13. Singh JA, Christensen R, Wells GA et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev 2009;CD007848.
14. Pope C, Mays N. Qualitative research in health care. 3rd edn. Malden, MA: Blackwell Publishing/BMJ Books, 2006.
15. Prince FH, Ferket IS, Kamphuis S et al. Development of a web-based register for the Dutch national study on Biologic treatment choice in JIA biologicals in JIA: www.ABC-register.nl. Rheumatology 200847:1413-6.
16. Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet 2001358:483-8.
17. College Van Zorgverzekeringen Medicijnkosten. http://www.medicijnkosten.nl (18 June 2012, date last accessed).
18. Tynjala P, Kotaniemi K, Lindahl P et al. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology 200847:339-44.
19. Vazquez-Cobian LB, Flynn T, Lehman TJ. Adalimumab therapy for childhood uveitis. J Pediatr 2006149:572-5.
20. Baraliakos X, Braun J. Spondyloarthritides. Best Pract Res Clin Rheumatol 201125:825-42.
21. Lin J, Ziring D, Desai S et al. TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008126:13-30.
22. Bradley CP. Uncomfortable prescribing decisions: a critical incident study. BMJ 1992304:294-6.
23. Buusman A, Andersen M, Merrild C et al. Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study. Scand J Prim Health Care 200725:208-13.
24. Jacoby A, Smith M, Eccles M. A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs. Br J Gen Pract 200353: 120-5.
25. Klein D, MacDonald A, Drummond N et al. A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders. Fam Pract 200623:659-65.
26. Chen CC, Bode RK. Factors influencing therapists' decision-making in the acceptance of new technology devices in stroke rehabilitation. Am J Phys Med Rehabil 201190: 415-25.